Indications for photodynamic therapy in age-related macular degeneration;Indications courantes de la photothérapie dynamique dans la dégénérescence maculaire liée à l'âge

Journal Francais d'Ophtalmologie

Volumn 27, Issue 1, 2004, Pages 79-80

  Soubrane, Gisèle ^a   Kuhn, D ^a   Coscas, G ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Choroidal new vessels; Exudative ARMD; Photodynamic therapy; Retreatment

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT; PORPHYRIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EXUDATE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LASER COAGULATION; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; RANDOMIZED CONTROLLED TRIAL; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; REVIEW; SUBRETINAL NEOVASCULARIZATION; TIME; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0842327328     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0181-5512(04)96098-6     Document Type: Article

References (3)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP Report 2. Arch Ophthalmol, 2001; 119:198-207.
2. Bressler NM. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol, 2002;133: 168-9.
3. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina, 2002;22:6-18.